| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2003;41:237.)
© 2003 American Heart Association, Inc.
Scientific Contributions |
From the Department of Geriatric and Metabolic Diseases, Second University of Naples, Naples Italy.
Correspondence to Dott Raffaele Marfella, Via Emilio Scaglione 141, 80145 Napoli, Italy. E-mail raffaele.marfella{at}unina2.it
| Abstract |
|---|
|
|
|---|
50 mm Hg and/or diastolic BP
22 mm Hg during early morning (6:00 to 10:00 AM) compared with mean BP during the night. Clinical characteristics of patients with morning BP peak (MP+, n= 69, morning systolic BP=+54±4, diastolic BP=+32±5 mm Hg) did not differ from patients without BP peak (MP-, n= 87, morning systolic BP=+24±5, diastolic BP=+19±3 mm Hg). The daytime (10:00 AM to 10:00 PM) and the nighttime (10:00 PM to 6:00 AM) BP profile did not differ between the two groups. During daytime and nighttime ECG monitoring, the corrected QT (QTc) interval, and QTc dispersion did not differ significantly between the two groups, whereas during the morning period the QT values were significantly broader in the MP+ group compared with the MP- group (P
0.001). Morning LF/HF ratio was significantly higher in MP+ patients than in MP- patients (P
0.02). Both systolic and diastolic morning BP, in combination with ratio LF/HF power, were significant predictors of QTc dispersion (adjusted R2=0.59, P
0.01) and QTc interval (adjusted R2=0.41, P
0.01), whereas inclusion of physical activity and echocardiographic parameters did not add explanatory information. The prolongation of cardiac repolarization times and morning sympathetic overactivity coexist in hypertensive patients with morning BP peaks, and they might contribute to raised cardiovascular risk in these patients.
Key Words: hypertension, essential blood pressure sympathetic nervous system
| Introduction |
|---|
|
|
|---|
| Methods |
|---|
|
|
|---|
140 mm Hg and/or diastolic BP
90 mm Hg on at least 3 visits at 1-week intervals and fulfilled all of the following inclusion criteria: no clinical or laboratory evidence of heart failure, coronary heart disease, previous stroke, valvular defects, obesity, or secondary causes of hypertension; high-quality echocardiographic tracings; and at least 1 valid BP measurement per hour over 24 hours during ambulatory BP monitoring (ABPM). To exclude coronary heart disease, exercise testing, thallium scintigraphy, or both were performed when clinically indicated. Subjects engaged in regular physical training were excluded from the study. A physician measured clinic BP with a mercury sphygmomanometer in the hospital clinic before the beginning of ABPM, with the subject sitting for at least 10 minutes. The average of 3 measurements was considered for analysis. The arm with higher BP values at office evaluations was chosen for the ABPM, which was performed with Dyna Pulse 5000A (Pulse Metric, Inc). The cuff size for the ABPM was chosen individually according to the JNV VI guidelines.16 To reduce errors during the measurements caused by the position of the upper arm during the day, we asked all subjects to ensure that the arm was always parallel to the trunk when the cuff was inflated. Readings were obtained automatically at 15-minute intervals from 6:00 AM to 10:00 PM and 30-minute intervals from 10:00 PM to 06:00 AM by an oscillometric technique. All patients kept a diary in which they documented all the relevant events during the day as well as the time of waking and returning to bed. Daytime and sleep periods were derived from diary entries. Normal daily activities were allowed and encouraged, and subjects were told to keep their nondominant arm still and relaxed at their side during measurements. To abide by the actual wakefulness-sleep rhythm reported in subjects diaries, we defined daytime as between10:00 AM and 10:00 PM and nighttime as between 1:00 AM and 6:00 AM The morning BP peak was defined as a rise in systolic BP
50 mm Hg (90% percentile of normotensive patients)17 and/or diastolic BP
22 mm Hg18 during the early morning (6:00 to 10:00 AM), arbitrarily defined as the morning period, compared with the mean BP during the night. Subjects without a morning BP peak were defined as the MP- group and the others as the MP+ group. The normal values (mean±SD) of morning BP peak obtained from 18 normotensive patients 45±6 years of age were as follows: systolic, 21±5 mm Hg; diastolic, 12±4 mm Hg. Subjects with a nocturnal reduction of systolic and/or diastolic BP
10% were defined as dippers and the others as nondippers. Nighttime workers, subjects going to bed later than1:00 AM, and patient with sleep disordered breathing were excluded from the present study; therefore, all study subjects were in bed during the entire nighttime period and were awake and active during the morning and daytime interval.
On the same day, all subjects underwent 24-hour ambulatory ECG recording (H-SCRIBE, Mortara Instruments). A 2-channel bipolar recorder was used. The system was fully automatic and computerized; tracings were analyzed by two investigators who were unaware of the results of other investigations. The QT interval was measured from the earliest onset of the QRS complex to the terminal portion of the T wave, where it met the baseline. The R-R interval from the preceding cardiac cycle was measured from the peaks of the R waves to correct the QT interval for heart rate (QTc). QT intervals were corrected with Bazetts formula (QTc=QT/
R-R).19 QTc dispersion was calculated as interlead variability of the QTc interval (QTc dispersion=QTcmax-QTcmin). A cardiologist who was blinded from other information did the QT interval analysis with the aid of calipers and magnifying lens for 7 consecutive beats in lead II. Heart rate variability was analyzed in accordance with international guidelines.20 Three ECG leads (modified leadsV1, V5, and aVF) and a time signal to correct for tape speed irregularities were recorded. The 24-hour recordings were divided into 288 segments of 5 minutes. Twelve 5-minute segments were averaged to obtain hourly mean values of the heart rate variability parameters. All ectopic beats were classified, and only segments with <15%ectopy were used. Each nonnormal R-R interval was substituted by the subsequent R-R interval. Low-frequency (LF) (0.05 to 0.15 Hz, mediated by interaction of sympathetic and vagal activity) and high-frequency (HF) (0.15 to 0.50 Hz, representing pure vagal activity) components were determined and expressed as normalized units during morning, day, and nighttime periods.
The M-mode echocardiographic study of the left ventricle was performed under 2-dimensional control. Measurements were taken according to the American Society of Echocardiography recommendations.21Only frames with optimal visualization of interfaces and showing simultaneously septum, left ventricular internal diameter, and posterior wall were used for reading. Two observers read tracings, and the mean value from at least 5 measurements per observer were computed. Left ventricular mass was calculated according to Troy et al22 and normalized both by body surface area and by height23to correct for the effect of overweight. A venous blood sample was obtained from all subjects for measurement of routine blood chemical analyses and plasma and urinary catecholamines (epinephrine and norepinephrine), and separate urine samples were obtained during the morning time (6:00 to 10:00 AM), daytime (10:00 AM to 10:00 PM), and nighttime (10:00 PM to 6:00 AM). Blood samples were immediately centrifuged at 3000 rpm for 15 minutes; urine samples and plasma were decanted and stored at -80°C until analysis. Catecholamines were measured with high-pressure liquid chromatography.
All subjects underwent standard 12-lead ECG to evaluate the QTc interval and QTc dispersion values, obtained as previously described.
Statistical Analysis
Data are presented as group mean±SD. A preliminary ANOVA was used to assess the significance within and between groups. Two-sample t tests were used for between-group comparisons. Linear regression and correlation were used to evaluate relations between variables. Multivariate regression analysis tested the independent association and contribution of changes in 24-hour ABPM, catecholamine levels, and LH/HF ratio with the dependent variables (QTc-d, QTc). A value of P<0.05 was considered significant. All calculations were made on an IBM PC computer (SPSS, Inc, version 9.0).
| Results |
|---|
|
|
|---|
|
|
|
|
Morning BP increases were significantly positively correlated with left ventricular posterior wall thickness (r=0.15, P=0.05 and r=0.16, P=0.02, respectively) and left ventricular internal diastolic diameter (r=0.19, P=0.01 and r=0.15, P=0.05, respectively). During daytime and nighttime ECG monitoring the QTc interval, QTc dispersion, QRS duration, and the average R-R interval did not differ significantly between the two study groups, whereas during morning time period the QT values were significantly broader and R-R intervals significantly shortened in the MP+ patients compared with MP- patients (Table 2). In MP+ patients, the parameters of QT interval showed a biphasic profile: the QTc interval and QTc dispersion moderately increased to their peak levels in the morning hours (between 6 to 9 AM) (QTc: from 414±22 to 481±27 ms, P<0.001; QTc dispersion: from 54±10 to 75±14 ms, P<0.001) and constantly decreased during the subsequent hours, finally reaching steady-state levels around 418 ms and 54 ms, respectively, at 1 PM (Figure 2). In MP- patients, the biphasic profile of the QTc interval and QTc dispersion was not observed, and the hourly values were significantly lower during the morning period compared with the MP+ patients (Figure 2).
The QTc interval (r=0.24, P=0.02) and QTc dispersion (r=0.28, P<0.01) had a positive correlation with morning diastolic BP increases, less significant positive correlation with morning systolic BP increases (r=0.16, P=0.04; r=0.18, P=0.05, respectively), and were significantly positively correlated with left ventricular posterior wall thickness (r=0.16, P=0.04 and r=0.18, P=0.01, respectively) and left ventricular internal diastolic diameter (r=0.18, P=0.02 and r=0.16, P=0.04, respectively). To rule out a possible confounding effect of the heart rate correction, we also analyzed the data by using QT dispersion and QT without correction for heart rate; the results and associations were similar (QT dispersion versus morning diastolic BP: r=0. 21 P<0.03; QT versus morning diastolic BP: r=0.16, P<0.04).
Table 2 shows the power spectral analysis of heart rate variability in each group of hypertensive patients. There were no significant differences among the groups for LF, HF, and LF/HF ratio during day and nighttime period. The morning LF/HF ratio was significantly higher in the MP+ groups than in the MP- groups. Moreover, a relative decrease in the HF component (with a significant increase in ratio LF/HF power) was observed in the MP+ group during the morning period (P<0.01); QTc dispersion and the QTc interval were positively correlated with morning LF/HF ratio (QTc-d, r=0.41, P<0.01; QTc, r=0.36, P<0.01).
Basal plasma catecholamine concentrations were similar in the two groups (Table 1). Urine flow did not differ between the morning, diurnal, and nocturnal collection between the two groups (MP-: morning, 0.9±0.1; day, 0.9±0.2; night, 1.0±0.1 mL/min, MP+: morning, 1.0±0.2; day, 0.9±0.1; night, 1.0±0.2 mL/min). In the MP- patients, both urinary output of epinephrine (5.7±1.1 µg) and norepinephrine (28.8±2.9 µg) were significantly lower (-29% for both, P<0.02) during the morning period compared with MP+ patients (epinephrine, 7.9±1.2 µg; norepinephrine, 41.5±4.3 µg). In the MP- group, diurnal and nocturnal catecholamine output (epinephrine,5.8±1.9 µg; norepinephrine, 34.1±7.4 µg) was not different from that of the MP+ group (epinephrine, 5.6±1.8 µg; norepinephrine, 36.8±2.4 µg; P=NS for both).
In a multiple regression analysis, both systolic and diastolic morning BP were significant predictors of QTc dispersion (adjusted R2=0.49, P<0.005) and QTc interval (adjusted R2=0.35, P<0.005) as well as in combination with ratio LF/HF power were significant predictors of QTc dispersion (adjusted R2=0.59, P<0.001) and QTc interval (adjusted R2=0.41, P<0.001), whereas inclusion of age, physical activity, echocardiographic parameters, and metabolic parameters did not add explanatory information. Nevertheless, urinary catecholamine (epinephrine and norepinephrine) levels were significantly associated with the increase of QTc dispersion (P<0.01, P<0.05, respectively) and the QTc interval (P<0.01, P<0.05, respectively).
| Discussion |
|---|
|
|
|---|
Some available studies report that the QT times are increased in association with an increased left ventricular mass index in hypertensive individuals.24,25 Our data confirm the association of delayed cardiac repolarization and left ventricular hypertrophy since MP+ patients had significantly longer QTc dispersion and QTc interval (only in the morning hours), longer left ventricular internal diastolic diameter, and thicker interventricular septum and left ventricular posterior wall compared with MP- patients. We also found a significant linear association between left ventricular posterior wall thickness and left ventricular internal diastolic diameter and morning BP increases. These findings support those by Gosse et al,26 who found that the systolic BP on arising was significantly better correlated than office BP with left ventricular mass index and wall thickness. Moreover, Kuwajima et al27 also reported a significant association between the changes in systolic BP after arising from bed and left ventricular mass index. As for the background for this association, the present study provides the first evidence of an association between left ventricular hypertrophy, morning BP peak, morning increases of LF/HF ratio (considered as a marker of sympathetic overactivity), and morning prolongation of cardiac repolarization times in never-treated subjects with essential hypertension. Although the probable cause of delayed cardiac repolarization times in hypertensive patients with morning BP peak may be left ventricular hypertrophy, Perkiomaki et al28 showed that left ventricular hypertrophy was correlated only with QT apex dispersion times but not with the dispersion of the whole QRS complex duration or the QTc interval, demonstrating that left ventricular hypertrophy results in a more marked inhomogeneity of the plateau phase of repolarization than in the downslope phase of repolarization or in the depolarization phase. Moreover, we observed in a multiple regression analysis that both systolic and diastolic morning BP in combination with ratio LF/HF power were significant predictors of QTc dispersion and the QTc interval, whereas inclusion of echocardiographic parameters did not add explanatory information. Thus, left ventricular hypertrophy could be a cofactor in the association between morning BP peak and prolongation of QT times.
The length of the QT interval, which is easily obtained from standard resting ECG, represents the time interval between the start of activation of the ventricle and completion of its repolarization. QT interval is influenced by the autonomic tone and represents an index of myocardial refractoriness and electrical stability; this is a critical determinant of ventricular fibrillation and sudden death.29 Dispersion of repolarization is a consequence of predominance of sympathetic nerve activity and might be responsible for a high risk of ventricular fibrillation.30 Sympathetic stimulation unopposed by vagal activity might induce ventricular electrical instability, resulting in a risk of arrhythmia and sudden death.31 An association between a prolonged QT interval and sudden cardiac death has been found in coronary artery disease, congestive heart failure, and in obese and hypertensive patients.32 Although a direct link between morning BP peak and sudden cardiac death has not yet been established, it might be hypothesized that the surge in BP may be a factor predisposing to ventricular arrhythmias by a QT lengthening. Consistent with this, sudden cardiac death in hypertensive patients presents a circadian variation with a peak at 6 to 9 AM,33 the same time when a physiological increase in BP occurs.34 There are several theoretical possibilities through which a morning-raised BP may influence cardiac repolarization time. First, an increase in afterload predisposes to electrophysiological changes and QTc lengthening.12 In experimental models, an increase in cardiac afterload has been shown to alter action potential durations through mechanoelectrical feedback.35 This may result in an altered dispersion of action potential repolarization in the ventricle. Direct effects of increased load on repolarization are probably caused by activation of stretch-activated, nonselective cation ion channels and changes in calcium handling.36 Second, the link between morning BP peak and increase of QTc dispersion may be represented by local myocardial ischemia inducing an electrical instability that might induce arrhythmias. In fact, local myocardial ischemia may determine marked electrophysiological heterogeneity between epicardium and endocardium.37 Last, the left ventricular hypertrophy, evidenced in patients with morning BP peak, might affect QTc and QTc dispersion: Myocardial hypertrophy may alter the ion channels that are operative during the early repolarization phase.38 Abnormalities in the potassium channels in hypertrophied myocytes have been shown to contribute to the prolongation of action potential duration.39 Moreover, it is tempting to speculate that a sudden rise in BP causes an acute hemodynamic burden, which might predispose the hypertrophied ventricular myocardium to initiate an arrhythmic event in response to trigger factors, such as sympathetic overactivity.40
In addition to BP, there are also morning variations of heart rate variability. Our study showed a significant relation between QTc dispersion, the QTc interval, morning BP peak, and altered sympathovagal balance, suggesting that sympathetic overactivity may be a common mechanism unifying all these alterations observed in hypertensive patients with morning BP peak. Morning increase in LF/HF ratio, considered as a marker of sympathetic overactivity and morning increase of urinary catecholamine levels observed in MP+ patients, might be responsible for both the morning rise in BP and cardiac time prolongation in hypertensive patients. Moreover, the variation of BP was positively correlated with that of LF/HF ratio during the morning period, whereas this association was not obtained during the day and nighttime period. Thus, BP variation might be related to variation of sympathetic nervous system activity in the morning period only. The variations observed during day and nighttime periods also support this line of reasoning. In fact, reductions in LF/HF ratio were associated with significant and parallel changes in QTc dispersion, the QTc interval, and morning BP. Moreover, QT intervals, morning BP, and LF/HF ratio showed a trend to normalize during day and nighttime periods, suggesting that the abnormalities found during morning period are functional in origin and not due to structural damage within the baroreflex pathway. In keeping with this conclusion, therapeutic approaches with ß-blockers41 decreased morning BP peak and improved baroreflex sensitivity in hypertensive patients. Finally, the multivariate analysis of our data showed that changes in morning BP and LF/HF ratio were associated with change in QTc-d and the QTc interval. Thus, the shortening of QTc dispersion and the QTc interval during day and nighttime periods was strictly associated with a decrease in morning BP and LF/HF ratio.
In conclusion, the prolongation of cardiac repolarization times and morning sympathetic overactivity coexist in hypertensive patients with morning BP peak and might contribute to their raised cardiovascular risk. A likely mechanism for this association is through sympathetic overactivity, which correlates with both morning BP and cardiac repolarization times. It will be important to address in future studies evaluating whether morning BP peak, combined with increased QT times and impaired heart rate variability, may specifically identify hypertensive patients with left ventricular hypertrophy who are at high risk for life-threatening arrhythmias and sudden death.
Perspectives
The prolongation of cardiac repolarization times and morning sympathetic overactivity coexist in hypertensive patients with morning blood pressure peak and might contribute to their raised cardiovascular risk. A likely mechanism for this association is through sympathetic overactivity, which correlates with both morning blood pressure and cardiac repolarization times. Thus, this study may explain the reason why in the early hours of the morning there have been observed the higher number of fatal and nonfatal cardiovascular events. Similarly, this study also gives important information to guide in the choice of right treatment in hypertensive patients with morning blood pressure peak.
However, it will be important address in future studies evaluating whether morning blood pressure peak, combined with increased QT times and impaired heart rate variability, may specifically identify hypertensive patients with left ventricular hypertrophy who are at high risk for life-threatening arrhythmias and sudden death.
Received September 25, 2002; first decision November 19, 2002; accepted November 25, 2002.
| References |
|---|
|
|
|---|
2. Hjalmarson A, Gilpin EA, Nicod P, Dittrich H, Henning H, Blacky AR, Smith SC Jr, Ricou F, Ross J Jr. Differing circadian patterns of symptom onset in subgroups of patients with acute myocardial infarction. Circulation. 1998; 80: 267275.
3. Siegel D, Black DM, Seeley DG, Hulley SB. Circadian variation in ventricular arrhythmias in hypertensive men. Am J Cardiol. 1992; 69: 344347.[CrossRef][Medline] [Order article via Infotrieve]
4. Willich SN, Levy D, Rocco MB, Tofler GH, Stone PH, Muller JE. Circadian variation in the incidence of sudden cardiac death in the Framingham heart study population. Am J Cardiol. 1987; 60: 801806.[CrossRef][Medline] [Order article via Infotrieve]
5. Mancia G, Parati G, Di Rienzo M, Zanchetti A. Blood pressure variability. In: Zanchetti A, Mancia G, eds. Pathophysiology of Hypertension. New York: Elsevier Science; 1997: 117169.Handbook of Hypertension, Vol 17.
6. Mancia G, Ferrari A, Gregorini L, Parati G, Pomidossi G, Bertinieri G, Grassi G, Di Rienzo M, Pedotti A, Zanchetti A. blood pressure and heart rate variabilities in normotensive and hypertensive human beings. Circ Res. 1983; 53: 96104.
7. Muller JE. Circadian variation in cardiovascular events. Am J Hypertens. 1999; 12: 35S42S.[CrossRef][Medline] [Order article via Infotrieve]
8. Al-Khatib SM, Granger CB, Huang Y, Lee KL, Califf RM, Simoons ML, Armstrong PW, Van de Werf F, White HD, Simes RJ, Moliterno DJ, Topol EJ, Harrington RA. Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomes. Circulation. 2002; 106: 309312.
9. Manfredini R, Gallerani M, Portaluppi F, Fersini C. Relationships of the circadian rhythms of thrombotic, ischemic, hemorrhagic, and arrhythmic events to blood pressure rhythms. Ann N Y Acad Sci. 1996; 783: 141158.[Medline] [Order article via Infotrieve]
10. Rahn KH, Barenbrock M, Hausberg M. The sympathetic nervous system in the pathogenesis of hypertension. J Hypertens. 1999; 17 (suppl 3): S11S14.[Medline] [Order article via Infotrieve]
11. Schmieder RE, Messerli FH. Hypertension and the heart. J Hum Hypertens. 2000; 14: 597604.[CrossRef][Medline] [Order article via Infotrieve]
12. Yee KM, Lim PO, Ogston SA, Struthers AD. Effect of phenylephrine with and without atropine on QT dispersion in healthy normotensive men. Am J Cardiol. 2000; 85: 6974.[CrossRef][Medline] [Order article via Infotrieve]
13. Vlay SC, Mallis GI, Brown EJ Cohn PF. Documented sudden cardiac death in prolonged Q-T syndrome. Arch Intern Med. 1984; 144: 833834.
14. Zipes DP. The long QT syndrome: a Rosetta stone for sympathetic related ventricular tachyarrhythmias. Circulation. 1992; 84: 14141419.
15. Oikarinen L, Nieminen MS, Viitasalo M, Toivonen L, Wachtell K, Papademetriou V, Jern S, Dahlof B, Devereux RB, Okin PM. Relation of QT interval and QT dispersion to echocardiographic left ventricular hypertrophy and geometric pattern in hypertensive patients: the LIFE study: the Losartan Intervention For Endpoint Reduction. J Hypertens. 2001; 19: 18831891.[CrossRef][Medline] [Order article via Infotrieve]
16. Sixth report of the Joint National Committee of Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997; 157: 24132446.
17. Suzuki Y, Kuwajima I, Mitani K, Miyao M, Uno A, Matsushita S, Kuramoto K. The relation between blood pressure variation and daily physical activity in early morning surge in blood pressure. Nippon Ronen Igakkai Zasshi. 1993; 30: 841848.[Medline] [Order article via Infotrieve]
18. Leary AC, Struthers AD, Donnan PT, MacDonald TM, Murphy MB. The morning surge in blood pressure and heart rate is dependent on levels of physical activity after waking. J Hypertens. 2002; 20: 865870.[CrossRef][Medline] [Order article via Infotrieve]
19. Bazett HC. An analysis of time relations of the electrocardiogram. Heart. 1920; 7: 353370.
20. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Eur Heart J. 1996; 17: 354381.
21. Sahn DJ, DeMaria A, Kisslo J, Weyman A, the Committee on M-Mode Standardization of the American Society of Echocardiography. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978; 58: 10721083.
22. Troy BL, Pombo J, Rackley CE. Measurement of left ventricular wall thickness and mass by echocardiography. Circulation. 1972; 45: 602611.
23. De Simone G, Daniels SR, Devereux RB, Meyer RA, De Divitiis O, Alderman MH. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and the impact of overweight. J Am Coll Cardiol. 1992; 20: 12511260.[Abstract]
24. Chapman N, Mayet J, Ozkor M, Lampe FC, Thom SA, Poulter NR. QT intervals and QT dispersion as measures of left ventricular hypertrophy in an unselected hypertensive population. Am J Hypertens. 2001; 14: 455462.[CrossRef][Medline] [Order article via Infotrieve]
25. Buja G, Miorelli M, Turrini P, Melacini P, Nava A. Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death. Am J Cardiol. 1993; 72: 973976.[CrossRef][Medline] [Order article via Infotrieve]
26. Gosse P, Ansoborlo P, Lemetayer P, Clementy J. Left ventricular mass is better correlated with arising blood pressure than with office or occasional blood pressure. Am J Hypertens. 1997; 10: 505510.[CrossRef][Medline] [Order article via Infotrieve]
27. Kuwajima I, Mitani K, Miyao M, Suzuki Y, Kuramoto K, Ozawa T. Cardiac implications of the morning surge in blood pressure in elderly hypertensive patients: relation to arising time. Am J Hypertens. 1995; 8: 2933.[CrossRef][Medline] [Order article via Infotrieve]
28. Perkiomaki JS, Ikaheimo MJ, Pikkujamsa SM, Rantala A, Kesaniemi YA, Huikuri HV. Dispersion of the QT interval and autonomic modulation of heart rate in hypertensive men with and without left ventricular hypertrophy. Hypertension. 1996; 28: 1621.
29. Algra A, Tijssen JGP, Roelandt JRTC, Pool J, Lubsen J. QTc prolongation measured by standard l2-lead electrocardiography is an independent risk factor for sudden death due to cardiac arrest. Circulation. 1991; 83: 18881894.
30. Watanabe T, Ashikaga T, Nishizaki M, Yamawake N, Arita M. Association of insulin with QTc dispersion. Lancet. 1997; 350: 18211822.[CrossRef][Medline] [Order article via Infotrieve]
31. Zipes DP. The long QT syndrome: a Rosetta stone for sympathetic related ventricular tachyarrhythmias. Circulation. 1992; 84: 14141419.
32. Bednar MM, Harrigan EP, Anziano RJ, Camm AJ, Ruskin JN. The QT interval. Prog Cardiovasc Dis. 2001; 43 (5 suppl 1): 145.[Medline] [Order article via Infotrieve]
33. Willich SN, Levy D, Rocco MB, Tofler GH, Stone PH, Muller JE. Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study population. Am J Cardiol. 1987; 60: 801806.[CrossRef][Medline] [Order article via Infotrieve]
34. Weber MA. The 24-hour blood pressure pattern: does it have implications for morbidity and mortality? Am J Cardiol. 2002; 89: 27A-33A.[Medline] [Order article via Infotrieve]
35. Hansen DE. Mechanoelectrical feedback effects of altering preload, afterload, and ventricular shortening. Am J Physiol. 1993; 264: H423H432.[Medline] [Order article via Infotrieve]
36. Salmon AH, Mays JL, Dalton GR, Jones JV, Levi AJ. Effect of streptomycin on wall-stress-induced arrhythmias in the working rat heart. Cardiovasc Res. 1997; 34: 493503.
37. Horvath G, Racker DK, Goldberger JJ, Johnson D, Jain S, Kadish AH. Electrophysiological and anatomic heterogeneity in evolving canine myocardial infarction. Pacing Clin Electrophysiol. 2000; 23: 10681079.[CrossRef][Medline] [Order article via Infotrieve]
38. Kleiman RB, Houser SR. Calcium currents in normal and hypertrophied isolated feline ventricular myocytes. Am J Physiol. 1988; 255: H1434H1442.[Medline] [Order article via Infotrieve]
39. Kleiman RB, Houser SR. Outward currents in normal and hypertrophied feline ventricular myocytes. Am J Physiol. 1989; 256: H1450H1461.[Medline] [Order article via Infotrieve]
40. Piccirillo G, Germano G, Quaglione R, Nocco M, Ragazzo M, Marigliano V, Cacciafesta M. QT-interval variability and autonomic control in hypertensive subjects with left ventricular hypertrophy. Clin Sci (Lond). 2002; 102: 363371.[Medline] [Order article via Infotrieve]
41. Kaplan NM. Beta blockade in the primary prevention of hypertensive cardiovascular events with focus on sudden cardiac death. Am J Cardiol. 1997; 80: 20J22J.[CrossRef][Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
R. Marfella, M. Siniscalchi, M. Portoghese, C. Di Filippo, F. Ferraraccio, C. Schiattarella, B. Crescenzi, P. Sangiuolo, G. Ferraro, S. Siciliano, et al. Morning Blood Pressure Surge as a Destabilizing Factor of Atherosclerotic Plaque: Role of Ubiquitin-Proteasome Activity Hypertension, April 1, 2007; 49(4): 784 - 791. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jones, G. Atkinson, A. Leary, K. George, M. Murphy, and J. Waterhouse Reactivity of Ambulatory Blood Pressure to Physical Activity Varies With Time of Day Hypertension, April 1, 2006; 47(4): 778 - 784. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kario Caution for Winter Morning Surge in Blood Pressure: A Possible Link With Cardiovascular Risk in the Elderly Hypertension, February 1, 2006; 47(2): 139 - 140. [Full Text] [PDF] |
||||
![]() |
M. Bursztyn, T. Mengden, S. Uen, H. Vetter, R. Marfella, K. Esposito, P. Gualdiero, D. Guigliano, K. Kario, Y. Umeda, et al. Morning Blood Pressure Surge and the Risk of Stroke * Response Circulation, October 14, 2003; 108 (15): e110 - e111. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |